Filing
Spy
Filing
Spy
Home
About
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2017 Q3
23 of 25 quarters
Total Value
$2.95M
Total Shares
170.0K
Net Share Change
-779.8K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Miller Value Partners
$2.95M
170.0K
0.1%
TRIM
-779.8K
(-82.1%)
Miller Value Partners
$2.95M
170.0K shares
TRIM
-779.8K
(-82.1%)
HALO — Halozyme Therapeutics Inc - FilingSpy